E
xtranodal lymphoma occurs in about 40% of patients with lymphoma and has been de scribed in virtually every organ and tissue [1] . In decreasing order of frequency, the spleen, liver, gastrointestinal tract, pancreas, abdominal wall, genitourinary tract, adrenal, peritoneal cavity, and biliary tract are involved [2] [3] [4] [5] . Extranodal disease is more common with non-Hodgkin's lymphoma (NHL) than with Hodgkin's lymphoma and is often intermediate-to high-grade [2, 3] . AIDS-related lymphoma and post trans plantation lymphoproliferative dis order (PTLD) are more likely to affect extra nodal sites and are of higher grade [2, 4, 5] . Diffuse large B-cell lymphoma and follicular lymphoma are the dominant histologic sub types in extranodal lymphoma. Mantle cell lymphoma, lympho blastic lymphoma, Burkitt's lymphoma, and mucosa-associated lymphoid tissue (MALT) lymphoma, however, are more likely to affect extranodal sites [2] . MALT lymphoma is a low-grade marginal zone B-cell lymphoma that is most commonly found in the stomach. It is closely associated with chronic inflammation, such as Helico bacter pylori gastritis, and has a clinically indolent course. Secondary involve ment of extranodal tissues as part of generalized lymphoma is signi ficantly more common than primary extra nodal disease, in which there is a dominant extranodal component with no or minor nodal in volve ment. Splenic, hepatic, or diffuse involvement of one or more extranodal organs indicates a more advanc-OBJECTIVE. The purpose of this article is to illustrate the spectrum of appearances of extranodal lymphoma in the abdomen using cross-sectional imaging techniques.
CONCLUSION. Extranodal lymphoma in the abdomen can mimic other neoplastic or inflammatory conditions. Although a definitive diagnosis is possible only with biopsy, it is important to consider extranodal lymphoma in the presence of certain imaging appearances in the appropriate clinical setting for the correct diagnosis, accurate staging, and optimal management.
Abdominal Manifestations of Lymphoma
examination. One hundred milliliters of 370 mg I/mL of iopromide (Ultravist 370, Bayer HealthCare) is administered IV at a rate of 2.5 mL/s. CT is performed after a 75-second delay. For 16-and 64-MDCT scanners, 0.75-and 0.6-mm detectors are used, respectively, with 120 kVp and 150-180 mAs. In suspected gastric or enteric in volve ment, CT is performed after the patient has drunk 1,000-1,500 mL of water or 2% sorbitol. In suspected colonic involvement, CT is performed after the administration of 500-1,000 mL of water or 2.5% di luted sodium amidotrizoate and meglumine amido trizoate (Gastrografin) as rectal contrast medium.
Routine PET/CT for the evaluation of lymphoma is performed after an IV injection of 370 MBq of 18 F-FDG that is administered 45-60 minutes before the scan. A low-dose CT acquisition is first performed (120 kVp, average of 64 mAs) from the skull base to the mid thigh, without IV or oral contrast material and no specific breath-holding instructions. A PET emission scan is immediately performed after the CT acquisition over the same range as CT, without changing the patient's position. Images are reconstructed with a 16-subset, two-iteration algorithm, 256 × 256 matrix, and a CT-based attenuation coefficient. In suspected gastric or enteric involvement, the study is performed after the patient has ingested 1,000-1,500 mL of water or 2% sorbitol. If colonic involvement is suspected, the study is performed after the administration of 500-1,000 mL of water as a rectal contrast medium. In suspected urinary tract involve ment, the study is per formed after IV hydration with 0.9% saline, an IV bolus of 20 mg of frusemide, and insertion of a urinary catheter.
At our institution, abdominopelvic MRI evaluation for lymphoma is performed with a torso phased-array coil. The protocol consists of axial 2D T1-and T2-weighted fast spinecho sequences; a coronal, fat-suppressed T2-weighted short tau inversion recovery sequence; and coronal breath-hold fat-sup pressed dynamic 3D T1-weighted gradient-echo sequences before and after the IV administration of gadolinium. In suspected gastric or enteric involvement, the study is performed after the patient has drunk 1,000-1,500 mL of water or 2% sorbitol. In suspected colonic involvement, the study is performed after the administration of 500-1,000 mL of water as a rectal contrast medium. An IV bolus of 20 mg of N-butyl scopolamine is administered when enteric or colonic disease is suspected.
Liver and Spleen
The spleen and liver are involved in 20-40% and up to 15% of patients with lymphoma, respectively [1] [2] [3] . The patterns of involvement include diffuse infiltration ( Fig. 1) , with or without organomegaly, and focal nodules (Fig. 2) . FDG PET/CT is more accurate than other cross-sectional tech niques for the detection of diffuse hepato splenic involvement [6] . Focal hepatosplenic lym phoma appears as cir cum scribed nodules that are hypoechoic, show no posterior acoustic enhancement on sono graphy, and are low-attenuation on contrast-enhanced CT. On MRI, the nodules may appear as hypo-or iso intense compared with normal spleen or liver on T1-weighted images and as hyper intense on T2-weighted images, and may show reduced enhancement after the admin istration of gadolinium. Focal hepato splenic lym pho mas can be in dis tin guishable from meta stases but are usually smaller and homo geneous and occur with extensive, bulky coalescent lymph nodes. Hepatosplenic fungal abscesses tend to be smaller and show hetero geneous enhance ment compared with lymphoma.
Gastrointestinal Tract
Extranodal lymphoma in the gastrointestinal tract occurs in 10-30% of all patients with NHL [2, 7] . The stomach, small bowel, pharynx, large bowel, and esophagus are involved in decreasing order of frequency [7] . The patterns of gastric involvement include polypoidal mass, diffuse or focal infiltration ( Fig. 3 ), ulcerative lesion, or mucosal nodularity [8] . The patterns of small-bowel involvement include solitary or multiple nod ules (Fig. 4) , circumferential wall thick ening with or without aneurysmal dilatation (Figs. 4 and 5), and direct extension from mesenteric nodes [7, 9] . The cecum and rectum are the most commonly involved parts of the large bowel. The patterns of large-bowel involvement include bulky poly poidal mass, infiltrative tumor (Fig. 6) , and aneurysmal dilatation [7] . Bowel per foration is an un com mon complication of gastro intestinal lympho ma but is more likely with T-cell lymphoma, with PTLD, and after chemo therapy or radiation therapy [5, [7] [8] [9] . Bowel obstruction is uncom mon at present ation despite significant lym phomatous in filtration of the bowel wall because of absent desmoplastic reaction [7, 9] . In contrast to gastrointestinal adenocarcin oma, lymphoma is more likely to involve multiple and longer segments of gut and is less likely to cause bowel obstruction [8] .
Genitourinary Tract
Renal involvement occurs in 3-8% of patients with lymphoma; the kidney is the most commonly involved part of the genito urinary tract [10] . The patterns of renal in volve ment, in descending order of frequency, include multiple circumscribed masses (Figs. 7 and 8 ), direct infiltration from adjacent nodes, a solitary mass, an isolated perinephric mass (Fig. 9) , and diffuse infiltration [10] (Fig. 10) . Renal metastases can mimic renal lym pho ma. Renal cell carcinomas can often be differentiated from renal lymphoma by their hypervascular enhancement pattern. Trans itional cell car cino ma and severe pyelo nephritis may mimic diffuse renal in filtration by lym pho ma. Exten sive bulky coalescent lymph nodes and absence of features of an infective process are supportive of the dia gnosis of lym pho ma. Predominant peri pelvic or renal sinus in volvement by lym pho ma is uncommon [10, 11] .
Despite peripelvic lymphoma encasing renal hilar structures, the vessels often remain patent, and there is often minimal hydronephrosis (Fig. 11) . This helps to differentiate peripelvic lymphoma from transitional cell carcinoma or metastases. The ureter is often affected by involved retroperitoneal nodes, but primary involvement of the ureter by lymphoma is rare [12] . About 8% of patients with lymphoma have bladder involvement at autopsy [10, 13] . The patterns of bladder involvement include circumscribed solitary or multiple masses (Fig. 12) and diffuse infiltration [13] . Transitional cell carcinoma may mimic bladder lymphoma. Approx imately 6% of patients with lymphoma have testicular involvement at autopsy [10] . Lympho ma is the most common testicular tumor in older men; bilateral involvement occurs in 38% of cases [1] . The patterns of testicular involvement include focal masses (Fig. 13 ) and diffuse infiltration with or without testicular enlargement [2] .
Pancreas
The pancreas is involved in about 30% of cases of NHL, usually from contiguous nodal infiltration [14] . The patterns of involvement include a circumscribed mass (Figs. 14 and 15) and diffuse glandular enlargement mimicking acute pancreatitis [14] . Although bile duct obstruction may occur with pancreatic lymphoma, moderate to severe dilatation of the main pancreatic duct despite a bulky tumor is uncommon. Vascular invasion, pancreatic atrophy distal to the tumor, and tumor calcification and necrosis are unusual
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at initial presentation [14] . These features can help to differentiate pancreatic lymphoma from adenocarcinoma.
Adrenal Gland
The adrenal gland is involved in about 4% of cases of NHL [1, 15] . Bilateral adrenal involve ment occurs in approximately 50% of these cases. The patterns of involvement include a rounded circumscribed homo geneous mass (Fig. 16 ) and an enlarged adrenal gland that main tains its normal shape [15] .
Biliary Tract
Lymphomatous involvement of the biliary tree is rare. The patterns of involvement of the gallbladder include an intraluminal polypoidal mass, a large mass replacing the gallbladder, and diffuse mural thickening [16] (Fig. 17) . The patterns of involvement of the bile ducts include a biliary stricture mimicking chol angio carcinoma and a focal mass [17] .
Peritoneum and Peritoneal Reflections
Peritoneal lymphomatosis is a rare clinical presentation that is often associated with highgrade primary gastrointestinal NHL and is radiologically indistinguishable from peri toneal carcinomatosis [18] . The patterns of involvement include discrete nodules, a diffuse infiltrative mass, and ascites (Fig. 18) . Exudative ascites from peritoneal lympho matosis shows high attenuation because of the increased proteinaceous content [18] . Loc u lat ed high-attenuation ascites and smooth peritoneal enhancement are more char ac ter istic of tuberculous peritonitis. Diffuse lym pho matous in filtration of the mesentery produces a stellate appearance of the mesen tery and causes fixation of the small-bowel loops (Fig. 18) .
Abdominal Wall
Lymphoma may involve the abdominal wall by direct extension from bone or may occur separately in the muscle, subcutaneous fat, or skin from hematogenous spread (Fig. 19) .
Conclusion
The wide spectrum of imaging appearances of extranodal lymphoma in the abdomen presented in this article should serve to alert the radiologist to consider its diagnosis in patients with or without a history of lymph oma in the presence of supportive collective imaging findings and suggestive clinical features. Although a definitive diagnosis of extranodal lymphoma is possible only with biopsy, certain findings (e.g., a bulky tumor of the gastrointestinal tract involving multiple segments with aneurysmal dilatation or without bowel obstruction; a bulky, homogeneous, noncalcified pancreatic mass with out significant dilatation of the main pan creatic duct; or a peripelvic renal mass without significant hydronephrosis) together with extensive bulky coalescent lymph nodes and absent features of an infective process are strongly suggestive of the diagnosis. Fig. 1-52 -year-old woman with large B-cell lymphoma involving spleen. Axial fused PET/CT image shows diffuse increased 18 F-FDG uptake in normal-sized spleen (arrow), indicating splenic involvement. 
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